Using the negFACS-IF:E/M strategy, TP53 mutations in spiked BT-549 and SK-BR-3 breast cancer cells from the peripheral blood of healthy donors were accurately detected without nonspecific signals (Figure 2A). Here, TP53 is linked to breast cancer.